Skip to content

Architect 4P52-11

by Abbott

Ref 04P5211

Architect 4P52-11 (04P5211) is an in vitro diagnostic device (EU IVDR Class C; FDA Class II) made by Abbott, registered in EUDAMED on 23 Aug 2026 (Basic UDI-DI 038074ARP0452PH) and listed in FDA GUDID since 9 Sep 2016 (UDI-DI 00380740102739), active as of 7 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number038074ARP0452PH Basic UDI-DI 00380740102739UDI-DIDate23 Aug 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00380740102739 UDI-DI Date9 Sep 2016ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Hemoglobin A1c Controls
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI 038074ARP0452PH registered 23 Aug 2026 Active
  • FDA GUDID UDI-DI 00380740102739 listed 9 Sep 2016 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00380740102739
  2. Registered EUDAMED 038074ARP0452PH

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Architect
Generic name
Glycated haemoglobin (HbA1c) IVD, control
Device name
ARCHITECT Hemoglobin A1c
Model / Ref / Catalog
04P5211, 4P52-11
Primary DI / UDI-DI
00380740102739
Basic UDI-DI
038074ARP0452PH
FDA product code
PDJ, JJX, LCP, JIT
EMDN code
W0101050205 Diabetes controls
GMDN term
Glycated haemoglobin (HbA1c) IVD, control
Device class
Class C EUDAMED
Class II GUDID
Regulation number
862.1373, 862.1660, 864.7470, 862.1150
EU registration type
Standard device
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / referenceEUDAMED
04P5211
GUDID
4P52-11
Device classEUDAMED
Class C
GUDID
Class II

Device class is stated on each registry's own scale: Class C in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under DIABETES CONTROLS.

Other devices from Abbott

See all devices from Abbott →

Properties

  • Contains human tissues or cells
  • Contains substances of microbial origin
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (17, all answered No)